Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Atara Biotherapeutics, Inc.
| Metric | Atara Biotherapeutics, Inc. ATRAHealthcare |
|---|---|
| Quality Score | 36 / 100 |
| Revenue (latest) | $121M |
| Net income (latest) | $33M |
| Operating margin | 29.7% |
| Net margin | 27.1% |
| Return on equity | −84.9% |
| Return on assets | 161.5% |
| Return on capital (ROCE) | 675.0% |
| Debt / equity | — |
| Revenue growth (YoY) | −6.3% |
| Altman Z″ (distress) | -315.39 |
| Accruals / assets | 413.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.